Low-Dose Aspirin in the Primary Prevention of Cancer: The Women’s Health Study: A Randomized Controlled Trial

Cited by (796)

Items 201–300 of 796

  1. Use of Aspirin, Other Nonsteroidal Anti-Inflammatory Drugs, and Acetaminophen and Postmenopausal Breast Cancer Incidence
    Xuehong Zhang, Stephanie A. Smith‐Warner, Laura C. Collins, BERNARD A. ROSNER, Walter Churchill Willett, Susan E. Hankinson · 2012 · Journal of Clinical Oncology
  2. Antioxidant supplements for preventing gastrointestinal cancers
    Goran Bjelaković, Dimitrinka Nikolova, RG Simonetti, Christian Nyfeldt Gluud · 2004 · Cochrane Database of Systematic Reviews
  3. Aspirin Use and Reduced Risk of Pancreatic Cancer
    Harvey A. Risch, Lingeng Lu, Samantha A. Streicher, Jing Wang, Wei Zhang, Quanxing Ni, Mark S. Kidd, Herbert Yu, Yu-Tang Gao · 2016 · Cancer Epidemiology Biomarkers & Prevention
  4. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study
    kConFab Investigators, Rebecca D. Kehm, John Llewelyn Hopper, Esther M. John, Kelly‐Anne Phillips, Robert J. MacInnis, Gillian S. Dite, Roger Laughlin Milne, Yuyan Liao, Nur Zeinomar et al. · 2019 · Breast Cancer Research
  5. Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies
    Patrizia Ballerini, Annalisa Contursi, Annalisa Bruno, Matteo Mucci, Stefania Tacconelli, Paola Patrignani · 2022 · Frontiers in Pharmacology
  6. Aspirin Use and the Risk of Gastric Cancer: A Meta-Analysis
    Ping Yang, Yong Zhou, Bo Chen, Hong-Wei Wan, Guiqing Jia, Hai-Long Bai, Xiaoting Wu · 2009 · Digestive Diseases and Sciences
  7. Polymorphisms in the Vitamin D Receptor and Risk of Ovarian Cancer in Four Studies
    Shelley S. Tworoger, Margaret A. Gate, I-min M Lee, Julie E. Buring, Linda T. Titus-Ernstoff, Daniel William Cramer, Susan E. Hankinson · 2009 · Cancer Research
  8. Aspirin, NSAID, and Acetaminophen Use and the Risk of Endometrial Cancer
    Akila N. Viswanathan, Diane Feskanich, Eva S. Schernhammer, Susan E. Hankinson · 2008 · Cancer Research
  9. Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?
    Marek Z. Wojtukiewicz, Dominika Hempel, Ewa Sierko, Stephanie C. Tucker, Kenneth V. Honn · 2017 · Cancer and Metastasis Reviews
  10. Non-steroidal anti-inflammatory drugs and cancer risk in women: Results from the Women's Health Initiative
    Theodore M. Brasky, Jingmin Liu, Emily White, Ulrike Peters, John D. Potter, Roland B. Walter, Christina S. Baik, Dorothy S. Lane, JoAnn E. Manson, Mara Z. Vitolins et al. · 2014 · International Journal of Cancer
  11. Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drugs, or Acetaminophen and Risk of Ovarian Cancer
    Wei-Hsuan Lo-Ciganic, Janice C. Zgibor, Clareann H. Bunker, Kirsten B. Moysich, Robert P. Edwards, Roberta B. Ness · 2012 · Epidemiology
  12. Nonsteroidal Antiinflammatory Drugs and Breast Cancer Risk: The Multiethnic Cohort
    J. K. Gill, Gertraud Maskarinec, Lynne Ross Wilkens, Malcolm C. Pike, Brian E. Henderson, Laurence N. Kolonel · 2007 · American Journal of Epidemiology
  13. Frequency-Risk and Duration-Risk Relationships between Aspirin Use and Gastric Cancer: A Systematic Review and Meta-Analysis
    Xiaohua Ye, Jinjian Fu, Yi Yang, Yanhui Gao, Li Liu, Sidong Chen · 2013 · PLoS ONE
  14. Plasma C-Reactive Protein and Risk of Breast Cancer in Two Prospective Studies and a Meta-analysis
    Jun Wang, I-min M Lee, Shelley S. Tworoger, Julie E. Buring, Paul M. Ridker, BERNARD A. ROSNER, Susan E. Hankinson · 2015 · Cancer Epidemiology Biomarkers & Prevention
  15. C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results
    Renee C. Prins, Brooks L. S. Rademacher, Solange Mongoue‐Tchokote, Joshi J. Alumkal, Julie Nicole Graff, K. M. Eilers, Tomasz M. Beer · 2010 · Urologic Oncology Seminars and Original Investigations
  16. Low-dose aspirin use and the risk of ovarian cancer in Denmark
    Louise Baandrup, Susanne K. Kjær, Jørgen H. Olsen, Christian Dehlendorff, S. Friis · 2014 · Annals of Oncology
  17. Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein
    Daniel I. Chasman, Piotr Kozłowski, Robert Y.L. Zee, David J. Kwiatkowski, Paul M. Ridker · 2006 · Genes and Immunity
  18. Nonsteroidal Anti-Inflammatory Drugs and Risk for Ovarian and Endometrial Cancers in the Iowa Women's Health Study
    Anna E. Prizment, Aaron R. Folsom, Kristin E. Anderson · 2010 · Cancer Epidemiology Biomarkers & Prevention
  19. Low-Dose Aspirin and Medical Record–Confirmed Age-related Macular Degeneration in a Randomized Trial of Women
    William G. Christen, Robert J. Glynn, Emily Y. Chew, Julie E. Buring · 2009 · Ophthalmology
  20. Caffeine Consumption and the Risk of Breast Cancer in a Large Prospective Cohort of Women
    Ken Ishitani, Jennifer Lin, JoAnn E. Manson, Julie E. Buring, Shumin M. Zhang · 2008 · Archives of Internal Medicine
  21. C-Reactive Protein in the Prediction of Rheumatoid Arthritis in Women
    Nancy Ann Shadick · 2006 · Archives of Internal Medicine
  22. Nonsteroidal Anti-inflammatory Drugs and Subsite-Specific Colorectal Cancer Incidence in the Iowa Women's Health Study
    Amit Mahipal, Kristin E. Anderson, Paul J. Limburg, Aaron R. Folsom · 2006 · Cancer Epidemiology Biomarkers & Prevention
  23. Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management
    Amanda N. Fader, Anna Beavis, Anna Jo Bodurtha Smith · 2016 · International Journal of Women s Health
  24. Developmental windows of breast cancer risk provide opportunities for targeted chemoprevention
    Holly A. Martinson, Traci Renae Lyons, Erin Danielle Giles, Virginia F. Borges, Pepper S. Schedin · 2013 · Experimental Cell Research
  25. Association of High-Density Lipoprotein Cholesterol With Incident Cardiovascular Events in Women, by Low-Density Lipoprotein Cholesterol and Apolipoprotein B100 Levels
    Samia Mora, Julie E. Buring, Paul M. Ridker, Yadong Adam Cui · 2011 · Annals of Internal Medicine
  26. Dose–Risk and Duration–Risk Relationships between Aspirin and Colorectal Cancer: A Meta-Analysis of Published Cohort Studies
    Xiaohua Ye, Jinjian Fu, Yi Yang, Sidong Chen · 2013 · PLoS ONE
  27. HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women
    Emily B. Levitan, Simin Liu, Meir J. Stampfer, Nancy R. Cook, Kathryn M. Rexrode, Paul M. Ridker, Julie E. Buring, JoAnn Elisabeth Manson · 2007 · Diabetologia
  28. Association of phosphatidylcholine and nsaids as a novel strategy to reduce gastrointestinal toxixity
    Lenard M. Lichtenberger, Melisa Barron, Upendra K. Marathi · 2009 · Drugs of today
  29. C-reactive protein levels and subsequent cancer outcomes: Results from a prospective cohort study
    Kathy J. Helzlsouer, Thomas P. Erlinger, Elizabeth A. Platz · 2006 · European Journal of Cancer
  30. Breast Cancer Epidemiology
    James Vincent Lacey, Nadia T. Chung, Leslie Bernstein · 2012 · Elsevier eBooks
  31. NSAID use and breast cancer risk in the VITAL cohort
    Ann Ready, Christine M. Velicer, Anne McTiernan, Emily White · 2007 · Breast Cancer Research and Treatment
  32. Chemoprevention of Lung Cancer
    Eva M. Szabo, Jenny T. Mao, Stephen C. Lam, Mary E. Reid, Robert L. Keith · 2013 · CHEST Journal
  33. A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis
    Elizabeth W. Karlson, Lori Beth Chibnik, Monica McGrath, Shun‐Chiao Chang, Brendan T Keenan, Karen H. Costenbader, Patricia A. Fraser, Shelley S. Tworoger, Susan E. Hankinson, I-min M Lee et al. · 2009 · Arthritis Research & Therapy
  34. Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study
    Tobias Kurth, Paul E. de Jong, Nancy R. Cook, Julie E. Buring, Paul M. Ridker · 2009 · BMJ
  35. Aspirin in Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Review of the Balance of Evidence from Reviews of Randomized Trials
    Paul A Sutcliffe, Martin J Connock, Tara Gurung, Karoline Freeman, Samantha Ann Johnson, Ngianga‐Bakwin Kandala, Amy Grove, Binu Gurung, Sarah Morrow, Saverio Stranges et al. · 2013 · PLoS ONE
  36. Risk of colorectal cancer in self‐reported inflammatory bowel disease and modification of risk by statin and NSAID use
    Niloy Jewel Samadder, Bhramar Mukherjee, Shu‐Chen Huang, Jaeil Ahn, Hedy S. Rennert, Joel K. Greenson, Gad Rennert, Stephen B. Gruber · 2010 · Cancer
  37. Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults
    In Cheol Hwang, Jooyoung Chang, Kyuwoong Kim, Sang Min Park · 2018 · Scientific Reports
  38. Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium
    Britton L. Trabert, Elizabeth M. Poole, Emily White, Kala Visvanathan, Hans‐Olov Adami, Garnet L. Anderson, Theodore M. Brasky, Louise Annette Brinton, Renée T. Fortner, Mia M. Gaudet et al. · 2018 · JNCI Journal of the National Cancer Institute
  39. Aspirin and Cancer Risk: A Summary Review to 2007
    Cristina Bosetti, Silvano Gallus, Carlo La Vecchia · 2008 · Recent results in cancer research/Recent Results in Cancer Research
  40. Oral Contraceptives, Reproductive Factors, and Risk of Colorectal Cancer among Women in a Prospective Cohort Study
    Jessica J. Lin, S. M. Zhang, Nancy R. Cook, JoAnn Elisabeth Manson, Julie E. Buring, I-min M Lee · 2007 · American Journal of Epidemiology
  41. The Use of Animal Models for Cancer Chemoprevention Drug Development
    Vernon E. Steele, Ronald A. Lubet · 2010 · Seminars in Oncology
  42. Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis
    Aideen E. Ryan, Amy Colleran, Angela O'Gorman, Lisa O’Flynn, J Pindjacova, Paul Lohan, Grace O’Malley, M. Nosov, Coralie Mureau, Laurence John Egan · 2014 · Oncogene
  43. The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care
    Marina De Rosa, Daniela Rega, Valeria Costabile, Francesca Duraturo, Antonello Niglio, Paola Izzo, Ugo Pace, Paolo Delrio · 2016 · Therapeutic Advances in Gastroenterology
  44. Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity
    Karen J. Wernli, Polly A. Newcomb, John M. Hampton, Amy Trentham‐Dietz, Kathleen M. Egan · 2008 · British Journal of Cancer
  45. Aspirin and Nonsteroidal Anti-inflammatory Drug Use and Risk of Pancreatic Cancer: A Meta-analysis
    Susanna C. Larsson, Edward L. Giovannucci, Leif Bergkvist, Alicja Wolk · 2006 · Cancer Epidemiology Biomarkers & Prevention
  46. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype
    Theodore M. Brasky, Matthew R. Bonner, Kirsten B. Moysich, Christine B. Ambrosone, Jing Nie, Meng Hua Tao, Stephen B. Edge, Bhaskar Kallakury, Cătălin Marian, David S. Goerlitz et al. · 2011 · Cancer Causes & Control
  47. Chemoprevention – History and general principles
    Xiangwei Wu, Sherri L. Patterson, Ernest T. Hawk · 2011 · Best Practice & Research Clinical Gastroenterology
  48. Aspirin use and breast cancer risk: a meta‐analysis and meta‐regression of observational studies from 2001 to 2005
    Sandra Mangiapane, Maria Blettner, Peter Schlattmann · 2007 · Pharmacoepidemiology and Drug Safety
  49. Comparison of Self-Reported and Accelerometer-Assessed Physical Activity in Older Women
    Eric J. Shiroma, Nancy R. Cook, JoAnn Elisabeth Manson, Julie E. Buring, Eric B. Rimm, I-min M Lee · 2015 · PLoS ONE
  50. Plasma Lycopene, Other Carotenoids, and the Risk of Type 2 Diabetes in Women
    Lu Wang, Simin Liu, Aruna D. Pradhan, JoAnn Elisabeth Manson, Julie E. Buring, J. Michael Gaziano, Howard D. Sesso · 2006 · American Journal of Epidemiology
  51. Nonsteroidal anti‐inflammatory drugs and risk of lung cancer
    Sonia Hernández–Dı́az, Luis Alberto García Rodríguez · 2007 · International Journal of Cancer
  52. Vitamin E in the primary prevention of rheumatoid arthritis: The women's health study
    Elizabeth W. Karlson, Nancy Ann Shadick, Nancy R. Cook, Julie E. Buring, I-min M Lee · 2008 · Arthritis Care & Research
  53. Non-Steroidal Anti-Inflammatory Drugs Use Is Associated with Reduced Risk of Inflammation-Associated Cancers: NIH-AARP Study
    Fatma M. Shebl, Ann W. Hsing, Yikyung Park, Albert R. Hollenbeck, Lisa W. Chu, Tamra E. Meyer, Jill E. Koshiol · 2014 · PLoS ONE
  54. Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence
    Theodore M. Brasky, Ashley Sinclair Felix, David E. Cohn, Donald Scott McMeekin, David Gardner Mutch, William Thomas Creasman, Premal H. Thaker, Joan L. Walker, Richard G. Moore, Shashikant Lele et al. · 2016 · JNCI Journal of the National Cancer Institute
  55. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study
    Christina A. Clarke, Alison J. Canchola, Lisa M. Moy, Susan L. Neuhausen, Nadia T. Chung, James Vincent Lacey, Leslie Bernstein · 2017 · Breast Cancer Research
  56. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study
    Søren Friis, Lars Thomassen, Henrik Toft Sørensen, Anne Marie Tjønneland, Kim Overvad, Deirdre P Cronin-Fenton, Ulla Birgitte Vogel, Joseph K. McLaughlin, William J. Blot, Jørgen H. Olsen · 2008 · European Journal of Cancer Prevention
  57. Nonsteroidal Anti-inflammatory Drug Use and Serum Total Estradiol in Postmenopausal Women
    A. Hudson, Gretchen L. Gierach, Francesmary Modugno, Jennifer K. Simpson, John W. Wilson, Rhobert W. Evans, Victor G. Vogel, Joel L. Weissfeld · 2008 · Cancer Epidemiology Biomarkers & Prevention
  58. Aspirin and cancer: biological mechanisms and clinical outcomes
    P C Elwood, Majd B. Protty, Gareth Morgan, Janet E. Pickering, Christine Delon, John Watkins · 2022 · Open Biology
  59. Long-term aspirin use and cancer risk: a 20-year cohort study
    Charlotte Skriver, Thomas Maltesen, Christian Dehlendorff, Charlotte Wessel Skovlund, Morten Schmidt, Henrik Toft Sørensen, Søren Friis · 2023 · JNCI Journal of the National Cancer Institute
  60. Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial
    S. M. Zhang, Nancy R. Cook, JoAnn E. Manson, I-min M Lee, Julie E. Buring · 2008 · British Journal of Cancer
  61. Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer
    Sangmi Kim, David Shore, Lauren E. Wilson, Ethel I. Sanniez, Jae Hwan Kim, Jack A. Taylor, Dale P. Sandler · 2015 · BMC Cancer
  62. Low-dose aspirin use and cancer characteristics: a population-based cohort study
    F Jonsson, Li Yin, Cecilia Lundholm, Karin Ekstrom Ekstroem Smedby, Kamila Czene, Yudi Pawitan Y · 2013 · British Journal of Cancer
  63. Non-Steroidal Anti-Inflammatory Drugs and Melanoma Risk: Large Dutch Population-Based Case–Control Study
    Arjen Joosse, Elsje R. Koomen, Mariel K. Casparie, Ron M. C. Herings, Henk‐Jan Guchelaar, Tamar E. C. Nijsten · 2009 · Journal of Investigative Dermatology
  64. Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer
    Joanna L. Sylman, Annachiara Mitrugno, Garth W. Tormoen, Todd H. Wagner, Parag Mallick, Owen J. T. McCarty · 2017 · Convergent Science Physical Oncology
  65. Multifaceted Functions of Platelets in Cancer: From Tumorigenesis to Liquid Biopsy Tool and Drug Delivery System
    Melania Dovizio, Patrizia Ballerini, Rosa Fullone, Stefania Tacconelli, Annalisa Contursi, Paola Patrignani · 2020 · International Journal of Molecular Sciences
  66. Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case–control study
    Marie C. Bradley, Carmel M Hughes, Marie M. Cantwell, G Napolitano, Liam Murray · 2010 · British Journal of Cancer
  67. A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women
    Lu Wang, JoAnn Elisabeth Manson, Susanne Rautiainen, J. Michael Gaziano, Julie E. Buring, Michael Y. Tsai, Howard D. Sesso · 2015 · European Journal of Nutrition
  68. Drug Development for Cancer Chemoprevention: Focus on Molecular Targets
    Karen A. Johnson, Powel H. Brown · 2010 · Seminars in Oncology
  69. Current strategies for the prevention of breast cancer
    Alvaro Moreno-Aspitia, Pooja Prem Advani · 2014 · Breast Cancer Targets and Therapy
  70. Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: Current state-of-the science
    İbrahim Halil Şahin, Manal M. Hassan, Christopher R. Garrett · 2013 · Cancer Letters
  71. Regular Adult Aspirin Use Decreases the Risk of Non-Small Cell Lung Cancer among Women
    Alison L. Van Dyke, Michele L. Coté, Geoffrey M. Prysak, Gina B. Claeys, Angie S. Wenzlaff, Ann G. Schwartz · 2008 · Cancer Epidemiology Biomarkers & Prevention
  72. Nonsteroidal Antiinflammatory Drug Use and Breast Cancer Risk: Subgroup Findings
    Victoria A. Kirsh, Nancy Kreiger, Michelle Cotterchio, M. Sloan, B. Theis · 2007 · American Journal of Epidemiology
  73. A Randomized Trial of Low-Dose Aspirin in the Prevention of Clinical Type 2 Diabetes in Women
    Aruna D. Pradhan, Nancy R. Cook, JoAnn Elisabeth Manson, Paul M. Ridker, Julie E. Buring · 2008 · Diabetes Care
  74. Melanoma Chemoprevention: Current Status and Future Prospects
    Chhabra, Gagan, Ndiaye, Mary Ann, Garcia‐Peterson, Liz Mariely, Ahmad, Nihal · 2017 · Photochemistry and Photobiology
  75. Non-Steroidal Anti-Inflammatory Drug Use and Colorectal Polyps in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Christine Cole Johnson, Richard B. Hayes, Robert E. Schoen, Marc James Gunter, Wen‐Yi Huang · 2010 · The American Journal of Gastroenterology
  76. Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies
    Freija Verdoodt, Søren Friis, Christian Dehlendorff, Vanna Albieri, Susanne K. Kjær · 2015 · Gynecologic Oncology
  77. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms
    Ana Babić, Ying Bao, Zhi Rong Qian, Chen Yuan, Edward L. Giovannucci, Hugues Aschard, Peter L. Kraft, Laufey Thora Amundadottir, Rachael Z. Stolzenberg‐Solomon, Vicente Morales‐Oyarvide et al. · 2016 · Cancer Research
  78. Aspirin use and endometrial cancer risk and survival
    Tsuyoshi Takiuchi, Erin A. Blake, Koji Matsuo, Anil K. Sood, Theodore M. Brasky · 2017 · Gynecologic Oncology
  79. Use of Aspirin, Other Nonsteroidal Anti-inflammatory Drugs, and Acetaminophen and Risk of Breast Cancer Among Premenopausal Women in the Nurses' Health Study II
    A. Heather Eliassen, Wendy Y. Chen, Donna L. Spiegelman, Walter Churchill Willett, David J. Hunter, Susan E. Hankinson · 2009 · Archives of Internal Medicine
  80. Association of accelerometer-measured physical activity and sedentary behavior with incident cardiovascular disease, myocardial infarction, and ischemic stroke: The women's health study
    Peter‐Marske, Kennedy M., Evenson, Kelly R., Moore, Christopher C., Cuthbertson, Carmen C., Howard, Annie Green, Shiroma, Eric J., Buring, Julie E., Lee, I‐Min · 2023 · Journal of the American Heart Association
  81. High-Dose Aspirin Consumption Contributes to Decreased Risk for Pancreatic Cancer in a Systematic Review and Meta-analysis
    Xi-Jun Cui, Qiang He, Jianmin Zhang, Huijie Fan, Zheng-Fang Wen, Yanru Qin · 2013 · Pancreas
  82. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention
    Robert Benamouzig, Bernard Uzzan, Antoine Martin, Jacques Deyra, Julian Little, Bernard Girard, Stanislas Chaussade, for the APACC Study Group · 2010 · Gut
  83. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women
    Rob C.M. van Kruijsdijk, Frank L.J. Visseren, Paul M. Ridker, Johannes A N Dorresteijn, Julie E. Buring, Yolanda van der Graaf, Nancy R. Cook · 2014 · Heart
  84. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies
    Fangfang Zeng, Huishan Wei, Eng‐Kiong Yeoh, Zheqing Zhang, Zefang Ren, Graham A. Colditz, Shelley S. Tworoger, Xuefen Su · 2016 · Cancer Epidemiology Biomarkers & Prevention
  85. Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival
    Chen Yuan, Zhi Rong Qian, Ana Babić, Vicente Morales‐Oyarvide, Douglas Adam Rubinson, Peter L. Kraft, Kimmie Ng, Ying Bao, Edward L. Giovannucci, Shuji Ogino et al. · 2016 · Journal of Clinical Oncology
  86. Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study
    Joan Fortuny, Manolis Kogevinas, Michael S. Zens, Alan R. Schned, Angeline S. Andrew, John Heaney, Karl T. Kelsey, Margaret Rita Karagas · 2007 · BMC Urology
  87. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies
    Natalia I. Khalaf, Chen Yuan, Tsuyoshi Hamada, Yin Cao, Ana Babić, Vicente Morales‐Oyarvide, Peter L. Kraft, Kimmie Ng, Edward L. Giovannucci, Shuji Ogino et al. · 2017 · Gastroenterology
  88. Plasma Androgen Concentrations and Risk of Incident Ovarian Cancer
    Shelley S. Tworoger, I-min M Lee, Julie E. Buring, Susan E. Hankinson · 2007 · American Journal of Epidemiology
  89. Phenotypic and Genotypic Associations Between Migraine and Lipoprotein Subfractions
    Yanjun Guo, Iyas Daghlas, Padhraig Gormley, Franco Giulianini, Paul M. Ridker, Samia Mora, Tobias Kurth, Pamela M. Rist, Daniel I. Chasman · 2021 · Neurology
  90. Physical activity, adiposity, and risk of endometrial cancer
    Molly B. Conroy, Jacob R. Sattelmair, Nancy R. Cook, JoAnn Elisabeth Manson, Julie E. Buring, I-min M Lee · 2009 · Cancer Causes & Control
  91. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study
    Søren Friis, Aslak Harbo Poulsen, Henrik Toft Sørensen, Anne Marie Tjønneland, Kim Overvad, Ulla Birgitte Vogel, Joseph K. McLaughlin, William J. Blot, Jørgen H. Olsen · 2009 · Cancer Causes & Control
  92. Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study
    Mi Hee Cho, Tae Gon Yoo, Su‐Min Jeong, Dong Wook Shin · 2020 · Cancer Prevention Research
  93. Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO)
    Valerie McCormack, Rayjean J. Hung, Darren R. Brenner, Heike Bickeböller, Albert Rosenberger, Joshua E. Muscat, Philip J. Lazarus, Anne Marie Tjønneland, Søren Friis, David C. Christiani et al. · 2011 · Cancer Causes & Control
  94. Chemopreventive effects of aspirin at a glance
    Muhammad Waqas Usman, Fuwen Luo, Hai-Ling Margaret Cheng, Jean J. Zhao, Pixu Liu · 2015 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  95. Associations between dietary and lifestyle risk factors and colorectal cancer in the Scottish population
    Evropi Τheodoratou, Susan Mary Farrington, Albert Tenesa, Geraldine McNeill, Roseanne Cetnarskyj, Emmanouil Korakakis, Farhat V. N. Din, Mary E. Porteous, Malcolm G. Dunlop, Harry Campbell · 2013 · European Journal of Cancer Prevention
  96. Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study
    Theodore M. Brasky, Matthew R. Bonner, Kirsten B. Moysich, Christine B. Ambrosone, Jing Nie, Meng Hua Tao, Stephen B. Edge, Bhaskar Kallakury, Cătălin Marian, Maurizio Trevisan et al. · 2010 · Cancer Causes & Control
  97. Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies
    Yanpeng Zhang, Youdong Wan, Yuling Sun, Jian Li, Rongtao Zhu · 2015 · Scientific Reports
  98. Vitamin E Supplementation and the Risk of Heart Failure in Women
    Claudia U. Chae, Christine M. Albert, M. Vinayaga Moorthy, I-min M Lee, Julie E. Buring · 2012 · Circulation Heart Failure
  99. Lifestyle changes for prevention of breast cancer.
    Seyed Hesam Bani Hashemi, Samieh Karimi, Hamidreza Mahboobi · 2014 · PubMed Central
  100. Use of Nonsteroidal Anti-inflammatory Drugs and Risk of Ovarian and Endometrial Cancer: The Multiethnic Cohort
    Veronica Wendy Setiawan, Rayna Kim Matsuno, Galina Lurie, Lynne Ross Wilkens, Michael E. Carney, Brian E. Henderson, Laurence N. Kolonel, Marc T. Goodman · 2012 · Cancer Epidemiology Biomarkers & Prevention